EUVIMEDEUVIMED entdecken
Crossref

Neonatal‐Tissue‐Derived Extracellular Vesicle Therapy (NEXT): A Potent Strategy for Precision Regenerative Medicine

Peng Lou, Shuyun Liu, Yizhuo Wang, Ke Lv, Xiyue Zhou, Lan Li, Yong Zhang, Younan Chen, Jingqiu Cheng, Yanrong Lu, Jingping Liu iD

Advanced Materials · 2023

DOI: 10.1002/adma.202300602 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2023. Verfasst von Peng Lou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and NHC Key Laboratory of Transplant Engineering and Immunology, Frontiers Science Center for Disease-related Molecular Netw…. Hauptthemen laut MEDLINE: Regenerative Medicine, Extracellular Vesicles. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Natural Science Foundation of China, 1.3.5 Project for Disciplines of Excellence, West China Hospital of Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicle (EV)‐based therapies have emerged as a promising means in regenerative medicine. However, the conventional EV therapy strategy displays some limitations, such as inefficient EV production and lack of tissue‐specific repair effects. Here, it is reported that neonatal‐tissue‐derived EV therapy (NEXT) is a potent strategy for precision tissue repair. In brief, large amounts of EVs with higher yield/purity can be readily isolated from desired tissues with less production time/cost compared to the conventional cell‐culture‐based method. Moreover, source factors, such as age and tissue type, can affect the repair efficacy of such tissue‐derived EVs in different tissue injury models (skin wounds and acute kidney injury), and neonatal‐tissue‐derived EVs show superior tissue repair potency compared with adult‐tissue‐derived EVs. Different age‐ or tissue‐type‐derived EVs have distinct composition (e.g., protein) signatures that are likely due to the diverse metabolic patterns of the donor tissues, which may contribute to the specific repair action modes of NEXT in different types of tissue injury. Furthermore, neonatal‐tissue‐derived EVs can be incorporated with bioactive materials for advanced tissue repair. This study highlights that the NEXT strategy may provide a new avenue for precision tissue repair in many types of tissue injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Regenerative MedicineExtracellular VesiclesHumansInfant, NewbornCell- and Tissue-Based TherapyCell Culture Techniques

Stichwörter der Autor:innen

extracellular matrixextracellular vesicleskidney injuryregenerative medicinetissue-specific behaviorwound healing

Autor:innen und Institutionen

  • Department of Nephrology and NHC Key Laboratory of Transplant Engineering and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Institutes for Systems Genetics, West China Hospital, Sichuan University, Chengdu, 610041, China.

ORCID-Profile: Jingping Liu

Förderung

  • National Natural Science Foundation of China
  • 1.3.5 Project for Disciplines of Excellence
  • West China Hospital of Sichuan University

Zitieren

APA

Lou, P., Liu, S., Wang, Y., Lv, K., Zhou, X., Li, L., Zhang, Y., Chen, Y., Cheng, J., Lu, Y., & Liu, J. (2023). Neonatal‐Tissue‐Derived Extracellular Vesicle Therapy (NEXT): A Potent Strategy for Precision Regenerative Medicine. Advanced Materials. https://doi.org/10.1002/adma.202300602

Vancouver

Lou P, Liu S, Wang Y, Lv K, Zhou X, Li L, et al. Neonatal‐Tissue‐Derived Extracellular Vesicle Therapy (NEXT): A Potent Strategy for Precision Regenerative Medicine. Advanced Materials. 2023. doi:10.1002/adma.202300602

BibTeX
@article{Lou2023,
  author = {Lou, Peng and Liu, Shuyun and Wang, Yizhuo and Lv, Ke and Zhou, Xiyue and Li, Lan and Zhang, Yong and Chen, Younan and Cheng, Jingqiu and Lu, Yanrong and Liu, Jingping},
  title = {Neonatal‐Tissue‐Derived Extracellular Vesicle Therapy (NEXT): A Potent Strategy for Precision Regenerative Medicine},
  journal = {Advanced Materials},
  year = {2023},
  doi = {10.1002/adma.202300602}
}
Kostenlos starten →